Advisor Group’s Ra Pharmaceuticals RARX Stock Holding History
Bought
Maintained
Sold
Other funds holding RARX
BBA
Advisor Group's RARX Position: Q4 2019 in Review
Advisor Group reduced its Ra Pharmaceuticals (RARX) stake by 6.6% in Q4 2019, selling an estimated $575 and leaving 184 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4441.
Advisor Group first reported a position in RARX in Q1 2019 and has held it in 4 quarters since. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.
- Advisor Group held 184 shares of Ra Pharmaceuticals worth $9K as of Q4 2019.
- Advisor Group sold 13 Ra Pharmaceuticals shares in Q4 2019, an estimated $575.
- Ra Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4441 holding.
- Advisor Group first reported a position in Ra Pharmaceuticals in Q1 2019 and has held it in 4 quarters since.
- 146 funds tracked by Wall St. Rank held Ra Pharmaceuticals as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.